In recent years, the medical community has been grappling with the long-term effects of COVID-19, particularly concerning lung health. As the world continues to manage the aftermath of this virus, radiologists play a crucial role in diagnosing and monitoring post-COVID respiratory complications.
The precision oncology market is undergoing transformative developments driven by notable strategic partnerships. A profound alliance between RaySearch Laboratories AB (publ) and Radiology Oncology Systems, Inc. (ROS) is propelling this sector toward new dimensions, particularly in terms of
The Belgian Medical Imaging Platform (BELMIP) is leading an ambitious initiative aimed at revolutionizing radiology practices in Belgium by integrating evidence-based guidelines into clinical workflows. This effort seeks to address the increasing number of computed tomography (CT) scans performed
In an era where technology continually reshapes the medical landscape, the role of Artificial Intelligence (AI) in enhancing breast cancer screening represents a significant leap forward in diagnostic precision. AI systems, often described as an "additional set of eyes," are becoming indispensable
The journey of pancreatic cancer patient David Allard presents an extraordinary example of how innovative medical interventions can dramatically alter cancer outcomes. Initially diagnosed with stage IV pancreatic cancer, David faced a dire prognosis: less than six months to live. Refusing to accept
Positron emission tomography (PET) imaging has emerged as a vital tool in modern medical diagnostics, offering insights into the human body's molecular and cellular functions. At the forefront of this advancement are radiopharmaceuticals, specialized compounds that combine a radionuclide with a
